A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium

William Checkley(National Institutes of Health), A. Clinton White(The University of Texas Medical Branch at Galveston), Devan Jaganath(Johns Hopkins University), Michael J. Arrowood(Centers for Disease Control and Prevention), Rachel M. Chalmers(Public Health Wales), Xian‐Ming Chen(Creighton University), Ronald Fayer, Jeffrey K. Griffiths(Tufts University), Richard L. Guerrant(University of Virginia), Lizbeth Hedstrom, Christopher D. Huston(University of Vermont), Karen L. Kotloff, Gagandeep Kang(Christian Medical College & Hospital), Jan R. Mead(Atlanta VA Medical Center), Mark A. Miller(National Institutes of Health), William A. Petri(University of Virginia), Jeffrey W. Priest(Centers for Disease Control and Prevention), David S. Roos(University of Pennsylvania), Boris Striepen(University of Georgia), R.C.A. Thompson(Murdoch University), Honorine Ward, Wesley A Van Voorhis(University of Washington), Lihua Xiao(Centers for Disease Control and Prevention), Guan Zhu(Texas A&M University), Eric R. Houpt(University of Virginia)
The Lancet Infectious Diseases
September 30, 2014
Cited by 1,006Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis